Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Geddes

Showing results (151-160 of 159) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 159 results.
International Urology and Nephrology|August 28, 2013
Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinomaPing L Zhang, Joseph W Mashni, Venkata S Sabbisetti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2009
Enhanced gastrointestinal motility with orally active ghrelin receptor agonistsSoratree Charoenthongtrakul, Derek Giuliana, Kenneth A Longo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2011
Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivityKenneth A Longo, Elizabeth K Govek, Anna Nolan, et al.
Journal of Chemical Information and Computer Sciences|May 1, 1997
The PRINTS database of protein fingerprints: a novel information resource for computational molecular biologyT K Attwood, H Avison, M E Beck, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2015
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelinesAnthony Cleare, C M Pariante, A H Young, et al.
Annals of Neurology|November 18, 2000
Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrationsH Houlden, M Baker, E McGowan, et al.
ACS Central Science|August 29, 2022
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative InfectionsErica N Parker, Brett N Cain, Behnoush Hajian, et al.
Acta Neuropathologica|July 10, 2020
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregatesPaula García-Huerta, Paulina Troncoso-Escudero, Di Wu, et al.
ACS Central Science|October 3, 2022
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections"Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Pageof 16

Showing results (151-160 of 159) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 159 results.
International Urology and Nephrology|August 28, 2013
Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinomaPing L Zhang, Joseph W Mashni, Venkata S Sabbisetti, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 3, 2009
Enhanced gastrointestinal motility with orally active ghrelin receptor agonistsSoratree Charoenthongtrakul, Derek Giuliana, Kenneth A Longo, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 22, 2011
Pharmacologic inhibition of ghrelin receptor signaling is insulin sparing and promotes insulin sensitivityKenneth A Longo, Elizabeth K Govek, Anna Nolan, et al.
Journal of Chemical Information and Computer Sciences|May 1, 1997
The PRINTS database of protein fingerprints: a novel information resource for computational molecular biologyT K Attwood, H Avison, M E Beck, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2015
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelinesAnthony Cleare, C M Pariante, A H Young, et al.
Annals of Neurology|November 18, 2000
Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is caused by PS-1 mutations that lead to exceptionally high amyloid-beta concentrationsH Houlden, M Baker, E McGowan, et al.
ACS Central Science|August 29, 2022
An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative InfectionsErica N Parker, Brett N Cain, Behnoush Hajian, et al.
Acta Neuropathologica|July 10, 2020
Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregatesPaula García-Huerta, Paulina Troncoso-Escudero, Di Wu, et al.
ACS Central Science|October 3, 2022
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with <i>In Vivo</i> Efficacy against Drug-Resistant Gram-Negative Infections"Erica N Parker, Brett N Cain, Behnoush Hajian, et al.
Pageof 16